MedPath

Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests

Not Applicable
Recruiting
Conditions
HIV Infections
Registration Number
NCT04880200
Lead Sponsor
University of Washington
Brief Summary

This project will develop, implement, and evaluate models for use of point-of-care nucleic acid testing (POC NAT) among HIV-negative persons seeking HIV testing, PEP, and PrEP and HIV-positive persons in community and clinical settings. Study aims #1 and #2 will evaluate the sensitivity and specificity of a qualitative POC NAT in persons not known to be HIV-positive and will determine the impact of its use on PrEP uptake and persistence among persons testing HIV-negative and on time to HIV continuum of care outcomes among persons testing HIV-positive. Aim #3 will implement a POC NAT-tailored behavioral intervention to evaluate impact on time to virologic suppression among PLWH receiving ART. Aim #4 will quantify the acceptability and feasibility of implementation of POC NAT in community and clinical settings and collect cost and related data for cost-effectiveness analyses. Finally, in Aim #5, a distinct but related study will compare the sensitivity, specificity, and agreement of multiple POC NATs over a range of HIV RNA levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
932
Inclusion Criteria
  • Persons who are HIV-positive and seeking care at Madison Clinic.
  • 18 years of age or older
  • Patient's provider is willing to deliver adherence intervention
  • Patient is getting a laboratory RNA viral load test that day.
  • Able to read and speak English
Exclusion Criteria
  • Patients of unknown HIV status
  • Patients who have participated in the study before

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Time to viral suppressionParticipants will be enrolled for up to 6 months

We will compare time to virologic suppression among participants randomized to the two arms.

Secondary Outcome Measures
NameTimeMethod
ParticipationParticipants will be enrolled for up to 6 months

We will use descriptive statistics to report on the proportion of Madison primary care providers (PCP)s willing to participate in the RCT and the proportion of patients who agree to study enrollment.

Trial Locations

Locations (1)

Madison Clinic

🇺🇸

Seattle, Washington, United States

Madison Clinic
🇺🇸Seattle, Washington, United States
Joanne Stekler
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.